Skip to main content

Table 1 Characteristics of the gastric cancer patient tumour samples analyzed for drug sensitivity

From: Benchmarking of gastric cancer sensitivity to anti-cancer drugs ex vivo as a basis for drug selection in systemic and intraperitoneal therapy

Sex

Age at tumour sampling

Stage at tumour sampling*

Histology

Prior chemotherapy

Male

39

Metastatic

Signet-ring cell

Yes

Female

58

Metastatic

Signet-ring cell

Yes

Male

60

Metastatic

Intestinal

Yes

Male

58

Localized

Diffuse

Yes

Female

71

Localized

Diffuse

Yes

Female

54

Metastatic

Signet-ring cell

Yes

Male

66

Localized

Intestinal

No

Male

75

Localized

Intestinal

Yes

Female

67

Metastatic

Diffuse

Yes

Male

74

Localized

Intestinal

Yes

Female

70

Localized

Intestinal

No

Male

70

Localized

Intestinal

Yes

Male

70

Localized

Intestinal

Yes

Female

61

Localized

Intestinal

No

Female

88

Localized

Intestinal

No

Male

74

Localized

Intestinal

Yes

  1. *Patients with localized disease underwent curative surgery and tumour sampling was from the primary tumour. Patients with metastatic disease had carcinosis, were planned for cytoreductive surgery and intraperitoneal chemotherapy and tumour sampling was from carcinosis.